Granules gets USFDA nod for ADHD treatment drug

Granules gets USFDA nod for ADHD treatment drug The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release capsules of Novartis Pharmaceuticals Corporation.

No comments:

Post a Comment